幽门螺杆菌（Helicobacter pylori，H. pylori）是一种微需氧的革兰氏阴性菌，生命力顽强，能在酸性的胃部环境中生存，主要寄居于胃黏膜 。它就像隐藏在胃部的 “小怪兽”，一旦感染，可能伴随人一生，即便经过治疗将其 “赶跑”，也有复发的可能。

Table 1. Recommended Treatments for Helicobacter pylori Eradication 23 Regimen Duration (days) Eradication Rates (%) Potential Reasons for Failure; Clarithromycin 500 mg 2 times/day + amoxicillin ...

Cite this: New Concepts of Resistance in the Treatment of Helicobacter pylori Infections - Medscape - Jun 01, 2008. Summary and Introduction A History of Treatment for H. pylori Infections ...

New guideline for Helicobacter pylori includes change to primary treatment recommendation. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 09 / 240904184524.htm ...

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...

Discover how atrophic gastritis silently damages stomach tissue while increasing cancer risk, often going undiagnosed for ...

A protein from Helicobacter pylori inhibits amyloid formation in both microbes and humans, offering new leads for ...

The global helicobacter pylori infections treatment market is on a robust growth trajectory, with its value projected to escalate from USD 638.3 million in 2023 to an impressive USD 1,260 million by ...

Cinclus Pharma AB (publ), a clinical-stage pharmaceutical company developing next generation treatments for acid-related diseases, today announced that the European Medicines Agency (EMA) and the US F ...